Zentiva Group a.s.
Industry
- Pharmaceuticals
- OTC, Consumer
- Generic Drugs
- Vaccines
Other Names/Subsidiaries
- Creo Pharmaceuticals
- Solacium Pharma
- Zentiva (pre Sanofi)
Latest on Zentiva Group a.s.
Lupin and Zentiva have announced a license and supply agreement for the commercialization of Lupin’s Cimzia (certolizumab pegol) biosimilar “across multiple markets globally.” “Zentiva will oversee co
Zentiva is poised to expand its consumer health offering in Europe with the acquisition of a portfolio of brands from Italy’s Aboca for an undisclosed sum. Taking effect on 30 June 2025, the deal will
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Will Try Camurus’s FluidCrystal D
Four biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo